Breast cancer drug increases risk of uterine cancer

A recent scientific study conducted by researchers Irish shows that breast cancer is taken by thousands of women. .

The Irish study found that taking tamoxifen for 10 years increased the risk of endometrial cancer by 1.5% to 3.5%.

Previous research suggests that tamoxifen inhibits the hormone estrogen from stimulating the growth of breast cancer, which can be administered as a treatment or preventive treatment for people with a family history of the disease.

Although the drug inhibits estrogen in breast tissue, it acts as a uterine hormone, increasing the risk of endometrial cancer in users.

According to the American Cancer Society Tamoxifen causes cancer of the endometrium in about one in every 500 women.

The findings were recently published in the British Journal of Surgery